Analytical Data
-
Gene name
AspF9
-
简介
AspF9 protein, characterized by a GPI-like anchor, incorporates a phosphoceramide lipid group. The specific anchor position for this protein remains undetermined. AspF9 Protein, Neosartorya fumigata (HEK293, His) is the recombinant AspF9 protein, expressed by HEK293 , with C-His labeled tag.
- Application
-
Alternative Names
Probable glycosidase crf1; Crh-like protein 1; crf1; AFUA_1G16190
-
Species
Others
-
Source
HEK293
-
Tag
C-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8J0P4
-
Expression Region
Q20-G370
-
Protein Length
Full Length of Mature Protein
-
Molecular Weight
37.5 kDa.
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AspF9 is a recombinant protein derived from the allergenic fungus Aspergillus fumigatus, which is known to be a significant cause of respiratory allergies and fungal infections, particularly in immunocompromised individuals. This protein is part of a larger family of allergens, and its study has gained attention due to its role in mediating immune responses in sensitive individuals. Research into AspF9 focuses on understanding its structure, function, and interaction with the immune system, as well as its potential as a target for therapeutic interventions, such as allergy immunotherapy. By elucidating the molecular mechanisms behind its allergenic properties, researchers aim to develop more effective diagnostic tools and treatments for individuals suffering from Aspergillus-related allergies and asthma. Furthermore, the recombinant form of AspF9 facilitates the study of its antigenic properties and allows for the evaluation of its potential use in vaccine development. The increasing prevalence of fungal allergies and infections underscores the importance of continuous research into fungal allergens like AspF9, ultimately contributing to better healthcare outcomes for affected populations.
